Infliximab-induced SLE-like syndrome involving the lung and pleura [1]

Lupus

Volumn 16, Issue 9, 2007, Pages 764-766

  Diri, E ^a   Tello, W ^b   Ratnoff, W D ^b   Nugent, Kenneth ^b  

^a and Health Sciences   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; INFLIXIMAB; PREDNISOLONE; STEROID;

ADULT; AGED; ANEMIA; BACKACHE; CASE REPORT; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FEVER; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; LUNG; LYMPHOCYTOPENIA; MALE; MYCOBACTERIUM TUBERCULOSIS; PLEURA; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS LIKE SYNDROME; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLEURA; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34948874666     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307080633     Document Type: Letter

References (15)

1. Lipsky PE, van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 2000; 343: 1594-1602.
2. Maini R, St. Clair EW, Breedveld F et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999; 354: 1932-1939.
3. Jacob CO. Tumor necrosis factor-α in autoimmunity: pretty girl or old witch? Immunol Today 1992; 13: 122-125.
4. Day R. Commentary: adverse reactions to TNF-α inhibitors in rheumatoid arthritis. Lancet 2002; 359: 540-541.
5. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA 2006; 295: 2275-2285.
6. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor-α neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
7. Gomez-Reino JJ, Carmona L, Valverde VR, Martin Mola E, Montera MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk. Arthritis Rheum 2003; 48: 2122-2127.
8. Charles PJ, Smeenk RJT, Dejong J, Feldman M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor a: findings in an open-label and randomized placebo-controlled trial. Arthritis Rheum 2000; 43: 2383-2390.
9. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys FM, De Keyser F. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity. Arthritis Rheum 2005; 52: 2192-2201.
10. DeBandt M, Sibilia J, Le Loet X et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005; 7: 545-551.
11. Good JT, King TE, Antony VB, Sahn SA. Lupus Pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84: 714-718.
12. Naylor B. Cytological aspects of pleural, peritoneal and pericardial fluids from patients with systemic lupus erythematosus. Cytopathology 1992; 3: 1-8.
13. Aringer M, Smolen JS. Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003; 5: 172-177.
14. Charles PJ. Defective waste disposal: does it induce autoantibodies in SLE? Ann Rheum Dis 2003; 62: 1-3.
15. Guo H, Leung CK, Chan LYY, Chan TM, Lai KN. The pathogenetic role of immunoglobulin G from patients with system lupus erythematosus in the development of lupus pleuritis. Rheumatology 2004; 43: 286-293.